TriangleNCT03833934 · OUTCOME
Prevalance of ALK Restance Mechanism: Bypass Track Resistance
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- 32 months
What was measured
To determine the prevalence of the various types of ALK resistance mechanisms as measured by NGS
Analysis population: Patients with detected ALK fusion
Groups in this outcome
ALK-positive NSCLC With Progression
Patients in this group signed consent, met eligibility criteria, and all had ALK-positive cancer of a primary lung lesion with systemic progression (excluding the central nervous system)
| Group | Source count |
|---|---|
| ALK-positive NSCLC With Progression | 27 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| ALK-positive NSCLC With Progression | 3 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 3
- denoms
- counts
- group Id
- OG000
- value
- 27
- units
- Participants
- description
- To determine the prevalence of the various types of ALK resistance mechanisms as measured by NGS
- groups
- description
- Patients in this group signed consent, met eligibility criteria, and all had ALK-positive cancer of a primary lung lesion with systemic progression (excluding the central nervous system)
- id
- OG000
- title
- ALK-positive NSCLC With Progression
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- Patients with detected ALK fusion
- reporting Status
- POSTED
- time Frame
- 32 months
- title
- Prevalance of ALK Restance Mechanism: Bypass Track Resistance
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice